Evotec SE EVO
NASDAQ EVO
$1.41 +0.07 (+5.20%)
As of: Oct 14, 2026 · 2:02 PM EDT

Evotec SE (EVO) Other financing activities (2025 - 2026)

Updated

Evotec SE's Other financing activities came in at -$1.75 million for the year ended Dec 31, 2025.

Analysis

Evotec SE (EVO) Other financing activities (2025 - 2026) Analysis & Trends

  • The figure for the year ended Dec 31, 2025 represents the highest annual Other financing activities since the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.61 Bn 35.31 Bn 1.44 Bn
2 Medpace Holdings 17.34 Bn 15.40 Bn 201.64 Mn
3 Charles River Laboratories International 14.63 Bn 13.82 Bn 363.37 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn
5 Fortrea Holdings 2.02 Bn 1.40 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 723.40 Mn -38.68 Mn 18.44 Mn
7 Evotec SE 502.55 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 63.08 Mn 26.73 Mn 1.61 Mn
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -8,065.27
Jun 30, 2025 -6,781.57
Mar 31, 2025 -6,962.42
API Access

Evotec SE Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EVO&period=max&api_key=YOUR_API_KEY